ESTRO Multidisciplinary Management of Breast Cancer 2017

Previous Page

Next Page

Page Background

NeoSphere pCR rates

• Significant increase pCR rate THP population

• Substantial antitumor effect with trastuzumab en

pertuzumab without chemotherapie